TheraRadar
← Back
Data updated: Mar 29, 2026

B BRAUN MEDICAL

NeurologyInfectious DiseaseDermatology
Pharma

B BRAUN MEDICAL is a pharmaceutical company focused on Neurology, Infectious Disease, Dermatology. Key products include PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER.

2015
Since
16
Drugs
-
Trials
51
Approved (2yr)

Key Drugs

PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
piperacillin sodium
7 indications · 2025
MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
meropenem
3 indications · 2015

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

HEPARIN SODIUM 2026-02-20
Labeling
HEPARIN SODIUM 2026-02-20
Labeling
MAGNESIUM SULFATE 2026-01-08
Manufacturing (CMC)
ROCURONIUM BROMIDE 2026-01-06
ACETAMINOPHEN 2025-12-05
ROCURONIUM BROMIDE 2025-10-24
LIDOCAINE HYDROCHLORIDE 2025-10-02
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-09-26
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 32%
3 drugs
Infectious Disease 25%
2 drugs Phase 1: 2
Dermatology 21%
2 drugs
Cardiovascular 11%
1 drugs
Metabolic 11%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

B BRAUN specialty
Infectious Disease, Dermatology, Metabolic, Cardiovascular
Merck big-pharma
Infectious Disease, Cardiovascular, Metabolic
Novo Nordisk big-pharma
Metabolic, Cardiovascular, Infectious Disease, Neurology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Neurology, Dermatology